[Retracted] Effect of Xiaoyutang Combined with Intraperitoneal Heat Perfusion Chemotherapy on Immune Function, Circulating mir, Prognosis, and Survival of Postoperative Patients with Colorectal Cancer

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr class="thead"><td class="align_left" rowspan="3">Grouping</td><td class="align_center" colspan="4">Average value (<span class="nowrap"><svg height="8.68572pt" id="M136" style="vertical-align:-0.0498209pt" version="1.1" viewbox="-0.0498162 -8.6359 8.13765 8.68572" width="8.13765pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M593 650H142L136 622C219 616 224 611 209 531L130 120C114 39 108 34 23 28L17 0H501C518 32 557 130 568 158L540 169C519 132 495 93 469 70C439 43 409 35 332 35C272 35 241 37 225 50C211 61 211 89 222 149L253 320H350C441 320 443 312 441 239H471L510 434H481C455 366 448 358 360 358H260L303 572C311 613 312 615 348 615H431C509 615 522 603 532 581C544 555 546 531 545 491L574 493C583 555 592 631 593 650Z"></path></g></svg>)</span></td><td class="align_center" colspan="2" rowspan="2">Log rank</td></tr><tr class="thead"><td class="align_center" rowspan="2">Estimate</td><td class="align_center" rowspan="2">Standard error</td><td class="align_center" colspan="2">95% confidence interval</td></tr><tr class="thead"><td class="align_center">Lower limit</td><td class="align_center">Upper limit</td><td class="align_center"><span style="width: 13.593ptpx;"><svg height="11.6412pt" id="M137" style="vertical-align:-0.04979992pt" version="1.1" viewbox="-0.0498162 -11.5914 13.593 11.6412" width="13.593pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M655 0V28C585 35 562 50 517 120C469 193 414 280 360 366C427 469 460 516 481 545C526 604 545 614 619 622V650H390V622C457 614 462 604 438 560C411 511 381 463 339 398C295 466 258 523 225 580C210 606 211 615 272 622V650H26V622C97 614 111 603 153 538C188 482 235 408 288 324C200 188 148 116 124 85C96 47 64 34 7 28V0H236V28C169 36 164 46 188 89C220 148 262 217 310 291C372 193 417 118 442 77C461 44 454 35 392 28V0H655Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,8.515,-5.741)"><path d="M414 144C384 79 371 75 317 75H135L276 221C367 316 408 376 408 465C408 570 327 635 237 635C179 635 131 609 100 575L42 494L67 471C94 510 138 565 205 565C277 565 321 517 321 435C321 348 258 270 195 195C146 137 88 81 33 26V0H411C423 44 433 88 446 135L414 144Z"></path></g></svg></span></td><td class="align_center"><span style="width: 8.15071ptpx;"><svg height="8.68572pt" id="M138" style="vertical-align:-0.0498209pt" version="1.1" viewbox="-0.0498162 -8.6359 8.15071 8.68572" width="8.15071pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M600 480C600 590 528 650 384 650H143L137 622C222 614 225 607 210 531L130 127C113 41 106 36 23 28L17 0H294L300 28C204 36 195 42 212 127L243 284L314 263C327 263 339 263 352 264C465 271 600 337 600 480ZM508 481C508 351 402 304 329 304C289 304 265 311 250 317L295 559C302 594 310 606 323 611C335 616 350 619 367 619C455 619 508 573 508 481Z"></path></g></svg></span></td></tr><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr><td class="align_left">Research group</td><td class="align_center">18.908</td><td class="align_center">1.038</td><td class="align_center">16.873</td><td class="align_center">20.942</td><td class="align_center" rowspan="3">5.151</td><td class="align_center" rowspan="3">0.023</td></tr><tr><td class="align_left">Control group</td><td class="align_center">16.766</td><td class="align_center">1.520</td><td class="align_center">13.786</td><td class="align_center">19.746</td></tr><tr><td class="align_left">Totality</td><td class="align_center">19.123</td><td class="align_center">1.039</td><td class="align_center">17.087</td><td class="align_center">21.159</td></tr><tr class="table-tr"><td colspan="7"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Mean and median survival time.</div>

Computational and Mathematical Methods in Medicine

tab6

Table 6

Table 6: [Retracted] Effect of Xiaoyutang Combined with Intraperitoneal Heat Perfusion Chemotherapy on Immune Function, Circulating mir, Prognosis, and Survival of Postoperative Patients with Colorectal Cancer 

Table 6 | [Retracted] Effect of Xiaoyutang Combined with Intraperitoneal Heat Perfusion Chemotherapy on Immune Function, Circulating mir, Prognosis, and Survival of Postoperative Patients with Colorectal Cancer 